Literature DB >> 24433240

Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma.

Erica Locatelli1, Maria Naddaka, Chiara Uboldi, George Loudos, Eirini Fragogeorgi, Valerio Molinari, Andrea Pucci, Theodoros Tsotakos, Dimitrios Psimadas, Jessica Ponti, Mauro Comes Franchini.   

Abstract

AIM: Targeted biocompatible nanoplatforms presenting multiple therapeutic functions have great potential for the treatment of cancer. MATERIALS &
METHODS: Multifunctional nanocomposites formed by polymeric nanoparticles (PNPs) containing two cytotoxic agents - the drug alisertib and silver nanoparticles - were synthesized. These PNPs have been conjugated with a chlorotoxin, an active targeting 36-amino acid-long peptide that specifically binds to MMP-2, a receptor overexpressed by brain cancer cells.
RESULTS: The individual and synergistic activity of these two cytotoxic agents against glioblastoma multiforme was tested both in vitro and in vivo. The induced cytotoxicity in a human glioblastoma-astrocytoma epithelial-like cell line (U87MG) was studied in vitro through a trypan blue exclusion test after 48 and 72 h of exposure. Subsequently, the PNPs' biodistribution in healthy animals and their effect on tumor reduction in tumor-bearing mice were studied using PNPs radiolabeled with (99m)Tc.
CONCLUSION: Tumor reduction was achieved in vivo when using silver/alisertib@PNPs-chlorotoxin.

Entities:  

Keywords:  alisertib; cancer; glioblastoma; nanoprecipitation; organic coating; polymeric nanoparticle; radiolabeling; silver nanoparticle; toxicity; tumor reduction

Mesh:

Substances:

Year:  2014        PMID: 24433240     DOI: 10.2217/nnm.14.1

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  43 in total

1.  Synthesis, Purification, Characterization, and Imaging of Cy3-Functionalized Fluorescent Silver Nanoparticles in 2D and 3D Tumor Models.

Authors:  Jessica Swanner; Ravi Singh
Journal:  Methods Mol Biol       Date:  2018

Review 2.  Silver nanoparticles as antimicrobial therapeutics: current perspectives and future challenges.

Authors:  Parteek Prasher; Manjeet Singh; Harish Mudila
Journal:  3 Biotech       Date:  2018-09-14       Impact factor: 2.406

Review 3.  Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates.

Authors:  Yongjun Cheng; Jinhua Zhao; Wenli Qiao; Kai Chen
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

Review 4.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

5.  Key Health Benefits of Korean Ueong Dry Root Extract Combined Silver Nanoparticles.

Authors:  Gitishree Das; Han-Seung Shin; Jayanta Kumar Patra
Journal:  Int J Nanomedicine       Date:  2022-09-15

Review 6.  Mitochondria-Targeted, Nanoparticle-Based Drug-Delivery Systems: Therapeutics for Mitochondrial Disorders.

Authors:  Sakshi Buchke; Muskan Sharma; Anusuiya Bora; Maitrali Relekar; Piyush Bhanu; Jitendra Kumar
Journal:  Life (Basel)       Date:  2022-04-29

Review 7.  Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.

Authors:  Jianing Meng; Vivek Agrahari; Ibrahima Youm
Journal:  J Neuroimmune Pharmacol       Date:  2016-07-23       Impact factor: 4.147

Review 8.  Nanoparticles and radiotracers: advances toward radionanomedicine.

Authors:  Edwin C Pratt; Travis M Shaffer; Jan Grimm
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-23

9.  Silver/silver chloride nanoparticles inhibit the proliferation of human glioblastoma cells.

Authors:  Mateus Eugenio; Loraine Campanati; Nathalia Müller; Luciana F Romão; Jorge de Souza; Soniza Alves-Leon; Wanderley de Souza; Celso Sant'Anna
Journal:  Cytotechnology       Date:  2018-09-10       Impact factor: 2.058

10.  Cancer cell targeting and therapeutic delivery of silver nanoparticles by mesoporous silica nanocarriers: insights into the action mechanisms using quantitative proteomics.

Authors:  Sandra Montalvo-Quiros; Guillermo Aragoneses-Cazorla; Laura Garcia-Alcalde; María Vallet-Regí; Blanca González; Jose L Luque-Garcia
Journal:  Nanoscale       Date:  2019-03-07       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.